Oncopeptides AB (publ) (ONPPF)
USD 0.27
(0.0%)
USD 0.27
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 106.48 Million SEK | 1015.98% |
| 2022 | 9.54 Million SEK | -32.77% |
| 2021 | 14.19 Million SEK | -26.67% |
| 2020 | 19.35 Million SEK | 190.97% |
| 2019 | 6.65 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 113.64 Million SEK | 6.72% |
| 2024 Q2 | 114.88 Million SEK | 1.09% |
| 2023 Q1 | 4.41 Million SEK | -53.74% |
| 2023 Q2 | 109.17 Million SEK | 2373.36% |
| 2023 FY | 106.48 Million SEK | 1015.98% |
| 2023 Q3 | 107.97 Million SEK | -1.09% |
| 2023 Q4 | 106.48 Million SEK | -1.38% |
| 2022 Q2 | 6.46 Million SEK | 1.79% |
| 2022 Q3 | 5.89 Million SEK | -8.92% |
| 2022 Q4 | 9.54 Million SEK | 62.0% |
| 2022 FY | 9.54 Million SEK | -32.77% |
| 2022 Q1 | 6.35 Million SEK | -55.24% |
| 2021 Q1 | 3.56 Million SEK | -81.56% |
| 2021 Q2 | 1.26 Million SEK | -64.47% |
| 2021 Q3 | 191 Thousand SEK | -84.94% |
| 2021 Q4 | 14.19 Million SEK | 7330.89% |
| 2021 FY | 14.19 Million SEK | -26.67% |
| 2020 Q2 | 12.77 Million SEK | 12.89% |
| 2020 Q1 | 11.31 Million SEK | 70.13% |
| 2020 FY | 19.35 Million SEK | 190.97% |
| 2020 Q4 | 19.35 Million SEK | 95.7% |
| 2020 Q3 | 9.89 Million SEK | -22.59% |
| 2019 Q2 | 4.1 Million SEK | -19.3% |
| 2019 FY | 6.65 Million SEK | 0.0% |
| 2019 Q1 | 5.08 Million SEK | 0.0% |
| 2019 Q3 | 3.12 Million SEK | -23.92% |
| 2019 Q4 | 6.65 Million SEK | 113.21% |
| 2018 Q2 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 20.32 Million USD | -423.844% |
| Skye Bioscience, Inc. | 4.61 Million USD | -2207.278% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -257.733% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -86828.163% |
| Qrons Inc. | 351.84 Thousand USD | -30165.144% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | -2160.191% |
| CSL Limited | 12.18 Billion USD | 99.126% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -145.514% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -1713.752% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -13981.782% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -133.729% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | 310 Thousand USD | -34250.645% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -16800.633% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -413940.204% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -158.445% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -2483.409% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -26399.257% |
| SQZ Biotechnologies Company | 27.47 Million USD | -287.634% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -4478.206% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -11129.596% |
| Mesoblast Limited | 118.7 Million USD | 10.289% |
| Marizyme, Inc. | 18.71 Million USD | -468.917% |
| Genus plc | 233.1 Million USD | 54.317% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -3533.887% |
| Pharming Group N.V. | 171.54 Million USD | 37.925% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -11890.915% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -7825.593% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -14098.267% |
| ContraFect Corporation | 2.88 Million USD | -3596.182% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -78495.732% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -7262.622% |
| IMV Inc. | 28.88 Million USD | -268.673% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -1781.943% |
| MultiCell Technologies, Inc. | 202.58 USD | -52565306.259% |
| ONE Bio Corp. | 19.71 Million USD | -440.131% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -85.23% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -7024.063% |
| Q BioMed Inc. | 4.1 Million USD | -2490.937% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -221.703% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -8569.031% |
| Biomind Labs Inc. | 735.54 Thousand USD | -14377.351% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -57.425% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -3418.846% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -719.32% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -29503.57% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -75146.258% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -4615.192% |
| GB Sciences, Inc. | 1.75 Million USD | -5952.781% |
| Alpha Cognition Inc. | 1.22 Million USD | -8625.782% |
| HST Global, Inc. | 98.31 Thousand USD | -108207.652% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -42714.008% |
| Halberd Corporation | 150 Thousand USD | -70891.333% |
| Enzolytics Inc. | 996.33 Thousand USD | -10587.839% |
| Agentix Corp. | 50 Thousand USD | -212874.0% |
| Resverlogix Corp. | 6.49 Million USD | -1540.533% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -41562.885% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -432.435% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -1405.583% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -3831.291% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -1041337.653% |
| Genscript Biotech Corporation | 417.73 Million USD | 74.509% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -52980.014% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -4341.17% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -46341.858% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -71534.13% |
| Kadimastem Ltd | 891.22 Thousand USD | -11848.372% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -42463.814% |
| LadRx Corporation | 33.6 Thousand USD | -316769.011% |
| Cell Source, Inc. | 9.25 Million USD | -1050.692% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -13981.782% |
| NovAccess Global Inc. | 2.19 Million USD | -4740.582% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -46527.725% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -50373.753% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -2037.006% |
| Mobile Lads Corp. | 484.28 Thousand USD | -21888.544% |
| CytoDyn Inc. | 30.07 Million USD | -254.06% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -1261.733% |
| SYBLEU INC | 477.5 Thousand USD | -22200.942% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -2148.8% |
| International Stem Cell Corporation | 4.17 Million USD | -2448.755% |
| Bioxytran, Inc. | 1.92 Million USD | -5431.792% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -170516.698% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -4782.709% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -1180.507% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -1140.384% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -6745.93% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -39633.955% |
| Neutra Corp. | 54.15 Thousand USD | -196530.106% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -5718.962% |
| PureTech Health plc | 25.51 Million USD | -317.4% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -8598.312% |
| IXICO plc | 472.02 Thousand USD | -22459.706% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -586.969% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -71.028% |
| CSL Limited | 12.18 Billion USD | 99.126% |
| Cellectis S.A. | 92.77 Million USD | -14.778% |